Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Payables: 2018-2021

Historic Payables for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $4.9 million.

  • Black Diamond Therapeutics' Payables rose 65.72% to $4.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $17.0 million, marking a year-over-year increase of 95.02%. This contributed to the annual value of $2.5 million for FY2020, which is 29.23% up from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Payables of $4.9 million as of Q3 2021, which was down 3.40% from $5.0 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Payables ranged from a high of $5.0 million in Q2 2021 and a low of $45,000 during Q2 2020.
  • In the last 3 years, Black Diamond Therapeutics' Payables had a median value of $3.4 million in 2020 and averaged $3.2 million.
  • Data for Black Diamond Therapeutics' Payables shows a peak YoY surged of 11,077.78% (in 2021) over the last 5 years.
  • Quarterly analysis of 4 years shows Black Diamond Therapeutics' Payables stood at $416,000 in 2018, then soared by 372.12% to $2.0 million in 2019, then increased by 29.23% to $2.5 million in 2020, then skyrocketed by 65.72% to $4.9 million in 2021.
  • Its Payables stands at $4.9 million for Q3 2021, versus $5.0 million for Q2 2021 and $4.6 million for Q1 2021.